Shoulder Innovations

Shoulder Innovations Graham Number

The Graham Number of Shoulder Innovations (SI) as of Nov 1, 2026 is 30.50 USD. In the previous year, Graham Number was 71.51 USD — a change of -57.35% (lower).

Graham Number

30.50USD

YoY

-57.35%

Last updated:

Graham Number of Shoulder Innovations is 2022 30.50 USD. Graham Number of Shoulder Innovations was 2021 71.51 USD. It decreases by -57.35% lower compared to the previous year.

The Shoulder Innovations Graham Number history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Graham Number
Date
Graham Number
Jan 1, 2016
5.23 USD
Jan 1, 2017
5.69 USD
Jan 1, 2018
15.82 USD
Jan 1, 2019
18.46 USD
Jan 1, 2020
20.90 USD
Jan 1, 2021
71.51 USD
Jan 1, 2022
30.50 USD
The Shoulder Innovations Graham Number history
YEARGraham NumberYoY
30.50USD-57.35%
71.51USD+242.20%
20.90USD+13.23%
18.46USD+16.64%
15.82USD+178.27%
5.69USD+8.64%
5.23USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shoulder Innovations Stock analysis

What does Shoulder Innovations do? Shoulder Innovations Inc generates revenue through its advanced implant systems for shoulder arthroplasty, specifically the aTSA and rTSA systems, which address patient and surgeon needs with customizable configurations for anatomic or reverse procedures. The company's ecosystem includes enabling technologies, instrument systems, specialized support, and surgeon-to-surgeon collaboration, enhancing preoperative planning, implant design, and procedural efficiency across the care chain. Its InSet Glenoid technology forms the foundational element of these systems, supporting comprehensive surgical solutions for healthcare providers. The firm targets hospitals and surgical centers as primary buyers, leveraging its commercial-stage medical technology focus to serve the shoulder surgical care market. The company's product portfolio centers on aTSA and rTSA systems, designed to improve core components of shoulder surgical care, with InSet Glenoid as the cornerstone of its implant solutions. These systems are sold to healthcare institutions seeking advanced surgical tools that streamline procedures and improve patient outcomes. Shoulder Innovations Inc capitalizes on its ecosystem approach, bundling implant systems with enabling technologies and support services to create a cohesive offering for medical professionals. The firm’s commercial-stage position allows it to directly engage with hospitals and surgical centers as key customers in the healthcare equipment and supplies sector. Shoulder Innovations Inc's revenue model relies on selling its advanced implant systems, including aTSA and rTSA, alongside InSet Glenoid technology, to hospitals and surgical centers. The company emphasizes procedural efficiency and preoperative planning through its ecosystem, which includes instrument systems and surgeon collaboration tools. By focusing on shoulder arthroplasty, the firm targets a specialized segment within the healthcare market, offering tailored solutions that address both patient requirements and surgical workflow optimization. The company’s products are designed to integrate seamlessly into existing surgical practices, enhancing care delivery across the shoulder surgical care chain. Shoulder Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shoulder Innovations stock

Graham Number of Shoulder Innovations is 30.50 USD in 2022.

On Eulerpool you can find the complete historical development of Graham Number Shoulder Innovations since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Shoulder Innovations

All Key Metrics — Shoulder Innovations